Remus Pharmaceuticals (NSE:REMUS) Interest Coverage : 32.21 (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Remus Pharmaceuticals's Operating Income for the six months ended in Mar. 2025 was ₹237 Mil. Remus Pharmaceuticals's Interest Expense for the six months ended in Mar. 2025 was ₹-7 Mil. Remus Pharmaceuticals's interest coverage for the quarter that ended in Mar. 2025 was 32.21. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Remus Pharmaceuticals's Interest Coverage or its related term are showing as below:

NSE:REMUS' s Interest Coverage Range Over the Past 10 Years
Min: 25.29 Med: 33.5 Max: 55.68
Current: 30.01

NSE:REMUS's Interest Coverage is ranked better than
67.03% of 91 companies
in the Medical Distribution industry
Industry Median: 7.15 vs NSE:REMUS: 30.01

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Remus Pharmaceuticals Interest Coverage Historical Data

The historical data trend for Remus Pharmaceuticals's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Remus Pharmaceuticals Interest Coverage Chart

Remus Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar24

Mar25

Interest Coverage

25.29

33.50

52.77

55.68

30.01

Remus Pharmaceuticals Semi-Annual Data
	Mar20	Mar21	Mar22	Sep23	Mar24	Sep24	Mar25
Interest Coverage	Get a 7-Day Free Trial			N/A	93.03	46.91	27.79	32.21

Competitive Comparison of Remus Pharmaceuticals's Interest Coverage

For the Medical Distribution subindustry, Remus Pharmaceuticals's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Remus Pharmaceuticals's Interest Coverage Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Remus Pharmaceuticals's Interest Coverage falls into.

Save Embed

;

Save Embed

;

Remus Pharmaceuticals Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Remus Pharmaceuticals's Interest Coverage for the fiscal year that ended in Mar. 2025 is calculated as

Here, for the fiscal year that ended in Mar. 2025, Remus Pharmaceuticals's Interest Expense was ₹-15 Mil. Its Operating Income was ₹438 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹50 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Mar. 2025 )	/	Interest Expense (A: Mar. 2025 )
	=	-1	*	438.2	/	-14.6
	=	30.01

Remus Pharmaceuticals's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Here, for the six months ended in Mar. 2025, Remus Pharmaceuticals's Interest Expense was ₹-7 Mil. Its Operating Income was ₹237 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹50 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	236.935	/	-7.357
	=	32.21

The higher the ratio, the stronger the company's Financial Strength is.

Remus Pharmaceuticals (NSE:REMUS) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Remus Pharmaceuticals Interest Coverage Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Remus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054

Website

https://www.remuspharma.com

Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines